Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
102 Cards in this Set
- Front
- Back
Why use multidrug and intensive induction approach for immunosuppressive therapy?
|
1. maximizes therapeutic effect since different drug act on different mechanisms.
2. synergistic effect allow for lower dosage and lower toxcity. |
|
What are the 7 mechanistic approaches of immunosuppressants?
|
1. inhibition of gene expression: glucocorticoids
2. antiproliferative and cytotoxic agents: antimetabolite, alkylating agents 3. inhibition of lympgocyte activation: calcineurin inhibitors, mTOR inhibitors. 4. neutralization of cytokines: TNF-α inhibitors, IL-1, IL-6 inhibitors. 5. antibodies to immune cells: polyclonal and monoclonal antibodies. 6. inhibition of costimulation. 7. inhibition of lymocyte adhesion and hoiming: Efalizumab, FTY720. 8. inhibition of complement activation: eculizumab. |
|
Which two of the following glucocorticoids are bound to cortisol-binding globulin and albumin?
A. Cortisol B. Prednisolone C. Methylprednisolone D. Dexamethasone |
A, B
|
|
Which is the drug to use for 1st dose cytokine release syndrome in transplant patients treated with anti-CD3 and to a lesser extent thymoglobulin?
|
Glucocorticoids.
|
|
How do glucocorticoids produce anti-inflammatory effect?
|
bind to GRE in the promotor region and stimulate expression of lipocortine to block PLA2, therefore production pro-inflammatory molecules is reduced.
|
|
Glucocorticoids have profound adverse effects such as growth retardation, osteronecrosis, osteoprosis, poor wound healing and so on. How do you minimize these side effects?
|
1. taper as soon and as rapidly as possible.
2. alternative-day dosing 3. use additional immunosuppressants or replace with nonsteroidal immunosuppressants. 4. Ca2+ and Vit D supplements and hormone replacement. |
|
Why do you need to slowly taper glucocorticoid dosage during termination of transplant therapy?
|
Abrupt cessation can result in acute adrenal insufficiency because the hypothalamus and pituitary gland require time to re-establish adequate ACTH production.
|
|
Which class of drug is AZA?
What is its mechanism of action? Which enzyme is required to turn it into the active drug mercaptopurine? |
1. Antimetabolite
2. Anti-proliferative and cytotoxic: depletes purine pool by inhibiting conversion of IMP to AMP and GMP. 3. glutathione |
|
Which drugs does AZA interact with?
|
1. allopurinal: inhibits xanthine oxidase which is needed in AZA degradation.
2. Other myelosuppressive agents or ACE inhibitors: will cause leukopenia, thrombocytopenia, and anemia. |
|
Which drug can not be used in conjunction with allopurinol or ACE inhibitors?
|
AZA
1. allopurinol: increases T1/2. 2. ACE inhibitors: leukopenia, thrombocytopenia, anemia. |
|
Which drug has toxicity of sepsis associated with CMV or viral infection when used with tacrlimus?
|
Mycophenolate mofetil
|
|
Which drug can not be used with mycophenolate mefetil?
|
1. Tacrolimus: impair converison of MPA to phenolic glucuronide.
2. antacids containing Al or Mg: decrease absorption. 3. cholestyramine: disrupt enterohepatic reabsorption by binding to bile acids. 4. acyclovir/gancyclovir: compete with pheolic glucuronide for tubular secretion. |
|
Which drug interacts with acyclovir?
|
Mycophenolate mofetil
|
|
Which drug interacts with antacids containing Al or Mg hydroxide?
|
Mycophenolate mofetil: decrease absorption.
|
|
Which antimetabolite interfere with purine sythesis?
A. AZA B. Mycophenolate mofetil C. Leflunomide D. Methotrexate |
A, B
|
|
Which antimetabolite interfere with pyrimidine sythesis?
A. AZA B. Mycophenolate mofetil C. Leflunomide D. Methotrexate |
C
|
|
Which is the most effective drug in reducing B cell populations?
A. AZA B. Mycophenolate mofetil C. Leflunomide D. Methotrexate |
C
|
|
Which two drugs interact with cholestyramine?
|
Mycophenolate mofetil
Leflunomide |
|
What is the mechanism of action of methotrexate?
|
Inhibit folate synthesis and induces apoptosis of CD4 and CD8 T cells.
May be related to increased adenosine level. |
|
What does a high level of adenosine cause?
Which drug might increase adenosine level? |
1. A potent anti-inflammatory agent: inhibit neutrophil superoxide generation, adhesion, and inhibits phagocytosis of IgG coated particles.
2. methotrexate |
|
Which antimetabolite drug can be used for cancer treatment?
|
Methotrexate
|
|
Which drug may cause pneumonitis characterized by patchy inflammatory infiltrates?
|
Methotrexate
|
|
Which drug is excreted unchanged in urine?
|
Methotrexate
|
|
Which population of people has higher sensitivity to methotrexate?
|
People with genetic polymorphism C677T
|
|
What are some drug interations with methotrexate?
|
1. drugs that compete to bind serum albumin
2. drugs that compete for tubular secretion 3. NAIDS: reduces renal blood flow. 4. Cisplatin: nephrotoxic. 5. Aspirin/Piperacillin: weak organic acids. |
|
Which drug interacts with NSAIDs and aspirin?
|
Methotrexate
|
|
Which drug interacts with cisplatin?
|
Methotrexate: nephrotoxic
|
|
Which drug is a derivative of nidrogen mustard?
|
cyclophosphamide
|
|
Which alkylation is the major mechanism of cytotoxicity in cyclophosphamide?
|
bis-alkylation
|
|
Which drug may cause childhood nephritic syndrome?
|
cyclophosphamide
|
|
Which is the drug that should avoid taking at night and can be detoxified by mesna?
|
cyclophosphamide
|
|
Which drug causes water intoxification at high dose?
|
cyclophosphamide: cause inappropriate secretion of vasopressin.
|
|
Which drug does leflunomide interact with?
|
Cholestyramine: quick removal and wash out of leflunomide becaused of interrupted enterohepatic circulation by cholestyramine binding with bile acids.
|
|
Name one transplant therapy drug whose initial dose is not given before transplantation. Why?
|
Cyclosporin A: concern of nephrotoxicity especially for renal transplant.
|
|
What is a major toxicity associated with cyclosporin A?
|
nephrotoxicity and renal dysfunction.
|
|
Which drug may cause tremor, hirsutism, gum hyperplasia?
|
cyclosporin A
|
|
Which drug can be used to treat uveitis and Behcet's acute ocular syndrome?
|
cyclosporin A
|
|
Name a drug that is a specific inhibitior of T cell-mediated immunity.
|
Cyclosporin A: block IL-2 expression, also increases TGF-β which inhibits IL-2 stimulated T cell proliferation.
Tacrolimus: similar mechanism. |
|
One of the toxicity of cyclosporin A is interstitial fibrosis. Explain.
|
Cyclosporin A increases expression of TGF-β that cause cells to produce ECM.
|
|
Are SANIMMUNE and NEORAL formulation of cyclosporin A bioeauivalent? Which one is more uniform and has higher bioavailability?
|
1. No.
2. NEORAL formulation |
|
Where is cyclosporin metabolized?
|
Liver: CYP3A. Dosage should be adjusted with hepatic dysfunction.
|
|
What are some drugs that can't be used with NSAIDS?
|
methotrexate
cyclosporin A *cyclosporin A elevateds methotrexate levels. |
|
What are some drug interactions with cyclodporin A?
|
1. P450 enzymes
2. sirolimus: aggrevates cyclosporinA induced renal dysfunction. The other way arround: hyperlipidemia, myelosuppression. 3. NSAIDS: renal dysfunction 4. elevated methotrexate 5. reduced clearance of prednisolone, digoxin statins. |
|
Which drug is a macrolide and more potent than cyclosporin?
|
Tacrolimus
|
|
Which drug causes hyperglycemia, glucose intolerance and diabetes mellutus?
|
Tacrolimus: negative effect on pancreatic islet β cells. (more than cyclosporin)
|
|
T/F: Cyclosporin A causes hyperurecemia and hyperlipidemia whereas tacrolimus dosen't.
|
T.
|
|
What are some drug interactions of tacromilus?
|
1. synergistic effect with cyclosporin A.
2. P450 enzymes 3. mycophenolate mofetil |
|
Which drug complexes with FKBP but does not affect calcineurin activity?
|
Sirolimus
|
|
How is sirolimus transported?
|
by P-glycoprotein
|
|
Which is the drug to pick in combination with glucocorticoids and mycophenolate mofetil to avoid calcineurin inhibitors and kidney dysfunction?
|
sirolimus
|
|
What is the drug that can be incorporated into stents to inhibit local cell proliferation and blood vessel occlusion in coronary heart disease?
|
sirolimus
|
|
Which drug increases serum cholesterol and TG and lymphocele?
|
sirolimus
|
|
Which drug interfere with sirolimus?
|
1. CYP3A4 substrates
2. drugs that transported by p-glycoprotein. 3. cyclosporin: renal dysfunction, hyperlipidemia, myelosuppression. |
|
T/F: Crohn's disease is mediated by Th2 response.
|
F. Should be Th1.
|
|
Which is the central inflammatory molecule in rheumatoid arthritis?
|
TNF-α
|
|
Name the six TNF-α inhibitors.
|
1. Etanercept: binds both TNF-α,β, treats RA, psoriatic arthritis, ankylosing arthritis.
2. Infliximab: treats RA and unresponsive Crohn's. 3. Adalimumab: RA, psoriatic arthritis, HIV arthropathy, wasting. 4. Certolizumab pegol: Crohn's, RA 5. Thalidomide: under investigation. 6. TACE inhibitor: under investigation. |
|
Which class of drug does Infliximab belong to? List the toxicities.
|
TNF-α inhibitors
infusion reaction TB, UTI anti-nuclear antibodies |
|
Which class of drug does Adalimumab belong to? List the toxicities.
|
TNF-α inhibitors
infusion reaction TB, UTI anti-nuclear antibodies |
|
Which class of drug does Certolimuzab pegol belong to? List the toxicities.
|
TNF-α inhibitors
headache, abdominal pain, cough, arthralgia nasopharyngitis, UTI, influenza, TB demyelinating disease |
|
Which class of drug does Etanercept belong to? List the toxicities.
|
TNF-α inhibitors
injection site reactions TB |
|
Which class of drug does Thalidomide belong to? List the toxicities.
|
TNF-α inhibitors
teratogenic |
|
Which class of drug does TACE inhibitors belong to? List the toxicities.
|
TNF-α inhibitors
liver toxicity |
|
Why pegylate Certolizumab?
|
increases half life
water soluble high motility lack toxicity |
|
Name the IL-1 inhibitor.
|
Anakinra: treats RA
|
|
Name the IL-6 inhibitor.
|
Tocilizumab: binds IL6 receptor, treats RA.
Toxicity: increased serum cholesterol, liver dysfunction, but no anti-DNA antibodies. |
|
Which class of drug does OKT3 belong to? List the toxicities.
|
monoclonal antibody: against CD3 on CD4 and CD8 T cells.
Toxicities: cytokine release syndrome. |
|
What is the drug to use when tranplant theray of cyclosporin A and glucocorticoids fail?
|
OKT3
|
|
Which class of drug does Declizumab and Basiliximab belong to? List the toxicities.
|
monoclonal antibody: against CD25(IL-2 receptor) on T cells.
Toxicities: hypersensitivity, neoplasia. |
|
Which drugs target CD25, part of IL2 receptor?
|
Daclizumab, Basiliximab
|
|
Which drugs target CD3?
|
OKT3
|
|
Which drugs target CD20 which is only expressed on B cells?
|
Rituximab
|
|
Which drug treats non-Hodgekins lymphoma and RA?
|
Rituximab
|
|
Which drugs target CD52 which is expressed on B, T, NK cells, monocytes, macrophages?
|
Alemtuzumab
|
|
Name the costimulation inhibitors.
|
1. Alefacept
2. Abatacept 3. Belatacept 4. Belimumab 5. Anti-CD40L antibody |
|
T/F: CD28 activate B7 whereas CTLA4 inhibits it.
|
T
|
|
Which drugs target CD2 which interact with LFA3 on APCs?
|
Alefacept: treat plaque psoriasis.
|
|
Which drug target the B7 binding region on CTLA-4, thus prevents CD28 from activating B7?
|
Abatacept: transpalnt therapy, RA.
Belatacept: similar, still under clinical trials. |
|
Which drug taget B lymphocyte stimulator BLYs/BAFF?
|
Belimumab: SLE, RA
|
|
Name the inhibitors of lymphocyte trafficking.
|
1. Efalizumab
2. Natalizumab 3. FTY720 |
|
Which class of drug does Efalizumab belong to? What is its action and therapeutic uses?
|
lymphocyte trafficking inhibitior: anti LFA-1(CD11)
Treat psoriasis Toxicity: infections. |
|
Which drug targets α4 intergrin (part of VLA4, LPAM1) on leukocytes and endothelial cells?
|
Natalizumab: treat relasping-remitting multiple sclerosis.
|
|
Which drug treats remitting multiple sclerosis?
|
Natalizumab
|
|
What is an agonist for sphigosine 1-phosphate receptor expressed on T and B cells?
|
FTY720
|
|
What is the function of sphigosine 1-phosphate receptor activation?
|
sequesters lymphocytes into lymph nodes and Peyer's patches, away from circulation.
|
|
What does FTY720 treat?
|
Acute rejection.
|
|
Which drug causes negative chronotropic effect on atrial myocytes?
|
FTY720
|
|
Which drugs treat IBD?
|
AZA
Cyclosporin A |
|
Which drugs treat SLE?
|
Anti-CD40L antibody (major)
Belimumab Leflunomide cyclosporin A |
|
Which drug treats myasthenia gravis?
|
Leflunomide
|
|
What are some anticancer drugs?
|
Methotrexate
Cyclophosphamide |
|
What drugs treat psoriasis?
|
Alefacept: severe form
Efalizumab Methotrexate Cyclosporin A |
|
Which drug is used for atopic eczema?
|
calcineurin inhibitors
|
|
What drug causes cytokine release syndrome?
|
ATG/ALG
OKT3 |
|
What drugs cause hypersensitivity?
|
Daclimumab
Basilixumab |
|
Which drug causes aseptic menigitis?
|
IGIV
|
|
What drugs interact with cholestyramine?
|
mycophenolate mofetil
leflunomide |
|
What do drugs that affect tubular secretion interfere with?
|
mycophenolate mofetil
methotrexate |
|
List 2 drugs that bind to serum albumin.
|
glucocorticoids
methotrexate |
|
Which drug interfere with aspirin?
|
methotrexate
|
|
Do calcineurin and mTOR inhibitors excrete in feces or in urine?
|
Feces
|
|
What drugs cause hypokalemia?
|
tacrolimus
sirolimus (also cause hyperkalemia) |
|
Which drug is used to treat non-Hodgekin's lymphoma?
|
Rituximab
|